Pfizer has released the names of the executives who will hold seniormanagement positions in the new Pfizer once the merger with Warner-Lambert is finalized in late May (Marketletters passim).
The Pfizer Inc corporate management committee, with responsibility for the group's four main operating units (Pfizer Pharmaceutical Group, Warner-Lambert Consumer Division, Pfizer Animal Health Group and Pfizer Global Research and Development) will comprise:
- William Steere - remains chairman and chief executive of Pfizer Inc;
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze